Drug Discovery in Hematology

Advancing novel therapeutic agents for the treatment of malignancy into the marketplace is an increasingly costly and lengthy process. As such, new strategies for drug discovery are needed. Drug repurposing represents an opportunity to rapidly advance new therapeutic strategies into clinical trials at a relatively low cost. Known on-patent or off-patent drugs with unrecognized anticancer activity can be rapidly advanced into clinical testing for this new indication by leveraging their known pharmacology, pharmacokinetics and toxicology. Using this approach, academic groups can participate in the drug discovery field and smaller biotechnology companies early-stage drug discovery projects. Here, several scientific approaches used to identify drug repurposing opportunities are highlighted with a focus on hematologic malignancies. In addition a discussion of the regulatory issues that are unique to drug repurposing and how they impact developing old drugs for new indications is included. Finally, the mechanisms to enhance drug repurposing through increased collaborations between academia, industry and nonprofit charitable organizations are discussed.

  • Biological Drugs
  • Generic Drugs
  • Cancer Pharmaceutical Companies

Related Conference of Drug Discovery in Hematology

September 18-19, 2017

International Conference on Cancer Biology R&D and Market

Philadelphia, Pennsylvania, USA
June 29-July 01, 2017

International Conference on Hematology and Oncology

Bangkok, Thailand
July 17-19, 2017

19th Euro Congress on Cancer Science and Therapy

Lisbon, Portugal
August 28-30, 2017

Oncologist & Diagnostics Conference

Brussels, Belgium
October 9-10, 2017

Global Meeting on Molecular & Cancer Biomarkers

Dubai, UAE
October 18-20, 2017

25th World Congress on Cancer Science and Therapy

Baltimore, Maryland, USA
October 19-20, 2017

15th World Oncologists Annual Conference

New York ,USA
Oct 19-21, 2017

25th World Cancer Conference

Rome, Italy
October 26-28, 2017

9th International Conference on Biomarkers

Osaka,Japan
November 06-08, 2017

2nd International Congress on Epigenetics & Chromatin

H4 Hotel Frankfurt Messe, Frankfurt, Germany
November 09-10, 2017

10th World Hematology and Oncology Congress

Vienna, Austria
November 16-17, 2017

World Cancer Meeting

Singapore
November 20-22, 2017

14th Asia Pacific
Oncologists Annual Meeting

Melbourne, Australia
November 27-28, 2017

26th World Cancer Convention

Dubai, UAE
November 27- 28, 2017

International Conference on Cancer Diagnostics

Dubai, UAE
December 07-08, 2017

9th World Biomarkers Congress

Madrid, Spain
May 24-25, 2018

22nd Global Annual Oncologists Meeting

Osaka, Japan

Drug Discovery in Hematology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in